EP 152: From Risk Factor to Treatment Target: The New Era of Cardiometabolic Medicine

In this key episode of Parallax, Dr Ankur Kalra sits down with Prof Naveed Sattar to explore how recent therapeutic breakthroughs are fundamentally reshaping the cardiologist's approach to diabetes management. Through real-world case discussions, Dr Sattar demonstrates practical decision-making for patients across the spectrum - from pre-diabetes to established CAD with Type 2 diabetes. He addresses the tension between robust evidence and cost barriers that limit widespread implementation, while acknowledging unprecedented patient demand driven by genuine quality of life improvements. The conversation concludes with insights on obesogenic environments and the hope that increased competition will ultimately democratize access to these transformative therapies. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

You can listen to EP 152: From Risk Factor to Treatment Target: The New Era of Cardiometabolic Medicine online on Radio and Podcast. Open the player on this page to stream the available audio.

EP 152: From Risk Factor to Treatment Target: The New Era of Cardiometabolic Medicine is an episode from Parallax by Ankur Kalra by Parallax by Ankur Kalra.

This episode is 00:38:33 long.

This episode was published on Feb 2, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Parallax by Ankur Kalra when more episodes are available from the podcast feed.